About: Primary Prevention Drug Therapy: Can It Meet Patients’ Requirements for Reduced Risk?

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Primary Prevention Drug Therapy: Can It Meet Patients’ Requirements for Reduced Risk? Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

Attributes	Values
rdf:type	Item
description	artículu científicu (ast) wetenschappelijk artikel (nl) наукова стаття, опублікована в серпні 2002 (uk) article scientifique publié en août 2002 (fr) im August 2002 veröffentlichter wissenschaftlicher Artikel (de)
publication date	wds:Q57745957-58D6DA6B-9167-4A72-A190-0DA401CA786A
publication date	2002-08-01 00:00:00Z (xsd:dateTime)
cites work	wds:Q57745957-06900121-FD80-4FA5-818A-642D0A8697E6 wds:Q57745957-1A57052D-203B-415D-8CD7-1A7E5232D098 wds:Q57745957-21673024-646E-4D84-850D-4F2C224621A0 wds:Q57745957-2C60D29E-EF00-4800-BA23-4AFC843464DA wds:Q57745957-35726E5E-E9B2-4DB7-AE4B-0791921EC81C wds:Q57745957-4B0EB1D7-2223-4FE8-AAEB-FB3B1C61869C wds:Q57745957-5F3404DF-F5DF-4399-BF12-DFA53B41A038 wds:Q57745957-67415627-5183-47CF-80B8-631E043950B2 wds:Q57745957-6D4308F9-07D0-4BA2-86BF-8F1109AA232C wds:Q57745957-7F55B2B2-B160-498D-857E-6886FB3D6041 wds:Q57745957-824B45BA-8CD0-4AFD-9B33-A3E6EFF9B2BE wds:Q57745957-82BE03E2-3595-4E68-84BA-8EA11CED668E wds:Q57745957-8733A68A-5DDA-4A39-8B8B-342E741BA08D wds:Q57745957-88CF3E69-491E-4EF8-A300-3060226CF128 wds:Q57745957-95EE985F-A0AB-4D45-911E-8BBDE50407E4 wds:Q57745957-9657B346-000D-4A55-9EB4-05191BD25D4C wds:Q57745957-B875F9E8-6A2C-41CB-BEB8-083481467D8D wds:Q57745957-BE3CDD97-9237-466D-9803-CCE898F8D5C3 wds:Q57745957-C820F3E2-9513-4323-A300-7BE91EE175F6 wds:Q57745957-CF757469-D40F-4550-B43A-18E1F96C7075 wds:Q57745957-CFF2EA43-76FC-44DB-B121-1324642F078A wds:Q57745957-E632F012-597B-4829-B31B-080E741E572D wds:Q57745957-F26135FD-2031-478C-B5A9-7259610692C9 wds:Q57745957-FA49F247-9A1A-4019-9F16-7671C7DDBC38
cites work	Trends in the Prevalence, Awareness, Treatment, and Control of Hypertension in the Adult US Population : Data From the Health Examination Surveys, 1960 to 1991 Risk-benefit assessment of drug treatment to prevent coronary heart disease. Estimating the benefits of risk factor modification Cholesterol lowering and mortality: the importance of considering initial level of risk Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease Assessing preferences about the DNR order: does it depend on how you ask? Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group Guidelines for managing raised blood pressure Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study An updated coronary risk profile. A statement for health professionals. Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study Indications for cholesterol-lowering medication: comparison of risk-assessment methods A simulation study of the number of events per variable in logistic regression analysis Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension A simple computer program for guiding management of cardiovascular risk factors and prescribing Trading treatment toxicity for survival in locally advanced non-small cell lung cancer. Eliciting preferences for alternative drug therapies in oncology: Influence of treatment outcome description, elicitation technique and treatment experience on preferences Do doctors accurately assess coronary risk in their patients? Preliminary results of the coronary health assessment study Assessing possible hazards of reducing serum cholesterol In the queue for coronary artery bypass grafting: patients' perceptions of risk and 'maximal acceptable waiting time'. Prevalence of high blood cholesterol among US adults. An update based on guidelines from the second report of the National Cholesterol Education Program Adult Treatment Panel. Cholesterol reduction yields clinical benefit. A new look at old data Science, ethics, and the making of clinical decisions. Implications for risk factor intervention Who benefits from medical interventions? Patients' willingness to enter clinical trials: measuring the association with perceived benefit and preference for decision participation.
author name string	wds:Q57745957-11F3F027-1600-44CF-9EF7-01406830A2EB wds:Q57745957-16EAE0FB-6B46-4CB3-909E-81F14A1F0340 wds:Q57745957-643E9FE7-B676-4CF6-B6BD-A2C59A8E720B wds:Q57745957-A3486CDB-3160-4FEE-B919-2EE00B2F6E92 wds:Q57745957-D65923DA-1FFE-436C-B1E9-8B8CB9695354 wds:Q57745957-DCA5CC0F-37A6-4805-B2DF-764A8EC5B427 wds:Q57745957-EA3C8E0F-54E1-4FB8-A09A-C1338A423441 wds:Q57745957-EFE01BB0-8E7A-4003-A895-320A967692DC wds:Q57745957-FE4E9870-443F-46DE-9CE5-5DF4A28957E8
author name string	Philip A. Wolf C. David Naylor Antoni Basinski Earl V. Dunn Gordon D. Hardacre Hilary A. Llewellyn-Thomas J. Michael Paterson Judy A. Carter Martin G. Myers
rdfs:label	Primary Prevention Drug Therapy: Can It Meet Patients’ Requirements for Reduced Risk? (en) Primary Prevention Drug Therapy: Can It Meet Patients’ Requirements for Reduced Risk? (nl)
skos:prefLabel	Primary Prevention Drug Therapy: Can It Meet Patients’ Requirements for Reduced Risk? (en) Primary Prevention Drug Therapy: Can It Meet Patients’ Requirements for Reduced Risk? (nl)
name	Primary Prevention Drug Therapy: Can It Meet Patients’ Requirements for Reduced Risk? (en) Primary Prevention Drug Therapy: Can It Meet Patients’ Requirements for Reduced Risk? (nl)
author	wds:Q57745957-71f77651-404e-c8b1-b4e1-222e079c19b9
author	Ralph B. D'Agostino Sr.
title	wds:Q57745957-2E935D44-F8F5-47A5-9E15-2C39F42E361D
title	Primary Prevention Drug Therapy: Can It Meet Patients’ Requirements for Reduced Risk? (en)
page(s)	wds:Q57745957-4E40A08F-2114-4094-8805-D90C2FF8FEF3
page(s)	326-339
instance of	wds:Q57745957-74AC8301-E177-4B01-9A6E-A8BF0729B2DF
instance of	scholarly article
PubMed ID	wds:Q57745957-46A014D5-3CB3-4D3B-9D09-CAF46BF3524F
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12150598
PubMed ID	12150598
published in	wds:Q57745957-D16E89B4-1CA5-4BEF-9AEB-CB071A4660C3
published in	Medical Decision Making
issue	wds:Q57745957-CF4C8588-6442-465A-AD71-63E9BF755CCE
volume	wds:Q57745957-D90BBDFA-9A32-40BB-8625-6398838F5C8E
issue	4
volume	22
DOI	wds:Q57745957-6C2B9849-F7E4-445F-8861-B30FE13E12A3
DOI	http://dx.doi.org/10.1177/0272989X0202200411
DOI	10.1177/0272989X0202200411

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 193 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software